The Metastasis-Associated Gene MTA3, a Component of the Mi-2/NuRD Transcriptional Repression Complex, Predicts Prognosis of Gastroesophageal Junction Adenocarcinoma

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Dong, Hongmei ^a,b   Guo, Hong ^a   Xie, Liangxi ^a   Wang, Geng ^a   Zhong, Xueyun ^c   Khoury, Thaer ^d   Tan, Dongfeng ^e   Zhang, Hao ^a,b  

^a CANCER HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^c MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER TISSUE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE REPRESSION; GENE STRUCTURE; GENETIC REGULATION; HUMAN; HUMAN TISSUE; LOWER ESOPHAGUS SPHINCTER; LOWER ESOPHAGUS SPHINCTER ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; MTA3 GENE; ONCOGENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR CELL LINE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CADHERINS; EPITHELIAL-MESENCHYMAL TRANSITION; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA, MESSENGER; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

GASTROPODA;

EID: 84877029852     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062986     Document Type: Article

References (34)

1. Moehler M, Lyros O, Gockel I, Galle PR, Lang H, (2008) Multidisciplinary management of gastric and gastroesophageal cancers. World J Gastroenterol 14: 3773-3780.
2. Menges M, Hoehler T, (2009) Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction. J Cancer Res Clin Oncol 135: 29-38.
3. Bain GH, Petty RD, (2010) Predicting response to treatment in gastroesophageal junction adenocarcinomas: combining clinical, imaging, and molecular biomarkers. Oncologist 15: 270-284.
4. Pedrazzani C, de Manzoni G, Marrelli D, Giacopuzzi S, Corso G, et al. (2007) Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg 134: 378-385.
5. Lagarde SM, ten Kate FJ, de Boer DJ, Busch OR, Obertop H, et al. (2006) Extracapsular lymph node involvement in node-positive patients with adenocarcinoma of the distal esophagus or gastroesophageal junction. Am J Surg Pathol 30: 171-176.
6. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, et al. (2006) The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 106: 1017-1025.
7. Maeda H, Okabayashi T, Nishimori I, Sugimoto T, Namikawa T, et al. (2008) Clinicopathologic features of adenocarcinoma at the gastric cardia: is it different from distal cancer of the stomach? J Am Coll Surg 206: 306-310.
8. Natsugoe S, Uchikado Y, Okumura H, Matsumoto M, Setoyama T, et al. (2007) Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma. Oncol Rep 17: 517-523.
9. Uchikado Y, Okumura H, Ishigami S, Setoyama T, Matsumoto M, et al. (2011) Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer. Gastric Cancer 14: 41-49.
10. Rosivatz E, Becker I, Specht K, Fricke E, Luber B, et al. (2002) Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol 161: 1881-1891.
11. He H, Chen W, Wang X, Wang C, Liu F, et al. (2012) Snail is an independent prognostic predictor for progression and patient survival of gastric cancer. Cancer Sci 103: 1296-1303.
12. Stanculescu D, Margaritescu C, Stepan A, Mitrut AO, (2011) E-cadherin in gastric carcinomas related to histological prognostic parameters. Rom J Morphol Embryol 52: 1107-1112.
13. Chan AO, (2006) E-cadherin in gastric cancer. World J Gastroenterol 12: 199-203.
14. Fearon ER, (2003) Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer. Cancer Cell 3: 307-310.
15. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, et al. (2003) MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113: 207-219.
16. Fujita N, Jaye DL, Geigerman C, Akyildiz A, Mooney MR, et al. (2004) MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell 119: 75-86.
17. Zhang H, Singh RR, Talukder AH, Kumar R, (2006) Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathway. Genes Dev 20: 2943-2948.
18. Zhang H, Stephens LC, Kumar R, (2006) Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Clin Cancer Res 12: 1479-1486.
19. Li X, Jia S, Wang S, Wang Y, Meng A, (2009) Mta3-NuRD complex is a master regulator for initiation of primitive hematopoiesis in vertebrate embryos. Blood 114: 5464-5472.
20. Singh RR, Kumar R, (2007) MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer. J Mammary Gland Biol Neoplasia 12: 115-125.
21. Manavathi B, Kumar R, (2007) Metastasis tumor antigens, an emerging family of multifaceted master coregulators. J Biol Chem 282: 1529-1533.
22. Bruning A, Juckstock J, Blankenstein T, Makovitzky J, Kunze S, et al. (2010) The metastasis-associated gene MTA3 is downregulated in advanced endometrioid adenocarcinomas. Histol Histopathol 25: 1447-1456.
23. Bruning A, Makovitzky J, Gingelmaier A, Friese K, Mylonas I, (2009) The metastasis-associated genes MTA1 and MTA3 are abundantly expressed in human placenta and chorionic carcinoma cells. Histochem Cell Biol 132: 33-38.
24. Dannenmann C, Shabani N, Friese K, Jeschke U, Mylonas I, et al. (2008) The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO. Cancer Biol Ther 7: 1460-1467.
25. Mylonas I, Bruning A, (2012) The metastasis-associated gene MTA3 is an independent prognostic parameter in uterine non-endometrioid carcinomas. Histopathology 60: 665-670.
26. Sobin LH, Compton CC, (2010) TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer 116: 5336-5339.
27. Kim SM, Park YY, Park ES, Cho JY, Izzo JG, et al. (2010) Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome. PLoS One 5: e15074.
28. Chen X, Leung SY, Yuen ST, Chu KM, Ji J, et al. (2003) Variation in gene expression patterns in human gastric cancers. Mol Biol Cell 14: 3208-3215.
29. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, et al. (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483: 603-607.
30. Gulmann C, Grace A, Leader M, Butler D, Patchett S, et al. (2003) Adenomatous polyposis coli gene, beta-catenin, and E-cadherin expression in proximal and distal gastric cancers and precursor lesions: an immunohistochemical study using tissue microarrays. Appl Immunohistochem Mol Morphol 11: 230-237.
31. Rosivatz E, Becker KF, Kremmer E, Schott C, Blechschmidt K, et al. (2006) Expression and nuclear localization of Snail, an E-cadherin repressor, in adenocarcinomas of the upper gastrointestinal tract. Virchows Arch 448: 277-287.
32. Lagarde SM, ten Kate FJ, Richel DJ, Offerhaus GJ, van Lanschot JJ, (2007) Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol 14: 977-991.
33. Nakamura M, Iwahashi M, Nakamori M, Naka T, Ojima T, et al. (2012) Lower mediastinal lymph node metastasis is an independent survival factor of Siewert type II and III adenocarcinomas in the gastroesophageal junction. Am Surg 78: 567-573.
34. Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, et al. (2012) Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol 19: 677-683.